It is noteworthy that when compared to healthy donors, in CML specimens, the HERC1 and HERC2 mRNA amounts are detected at lower levels in white blood cells precursors, as well as in mature white blood cells, as determined in BM and PB specimens. This evidence concerns the gene HERC2 and chronic myelogenous leukemia, BCR-ABL1 positive.